Health Advance Inc. Stock Other OTC
Equities
HADV
US42225L2034
Biotechnology & Medical Research
Financials (USD)
Sales 2015 | - | Sales 2016 | - | Capitalization | 1.23M |
---|---|---|---|---|---|
Net income 2015 | - | Net income 2016 | - | EV / Sales 2015 | - |
Net Debt 2015 | 72.77K | Net Debt 2016 | 98.54K | EV / Sales 2016 | - |
P/E ratio 2015 |
-39.9
x | P/E ratio 2016 |
-41.6
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 39.05% |
Managers | Title | Age | Since |
---|---|---|---|
Larry McLachlin
CEO | Chief Executive Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Larry McLachlin
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |